The V proteins of paramyxoviruses control the innate immune response. In particular, the V protein of the genus Morbillivirus interferes with the signal transducer and activator of transcription 1 (STAT1), STAT2, and melanoma differentiation-associated protein 5 (mda5) signaling pathways. To characterize the contributions of these pathways to canine distemper virus (CDV) pathogenesis, we took advantage of the knowledge about the mechanisms of interaction between the measles virus V protein with these key regulators of innate immunity. We generated recombinant CDVs with V proteins unable to properly interact with STAT1, STAT2, or mda5. A virus with combined STAT2 and mda5 deficiencies was also generated, and available wild-type and V-protein-knockout viruses were used as controls. Ferrets infected with wild-type and STAT1-blind viruses developed severe leukopenia and loss of lymphocyte proliferation activity and succumbed to the disease within 14 days. In contrast, animals infected with viruses with STAT2 or mda5 defect or both STAT2 and mda5 defects developed a mild self-limiting disease similar to that associated with the V-knockout virus. This study demonstrates the importance of interference with STAT2 and mda5 signaling for CDV immune evasion and provides a starting point for the development of morbillivirus vectors with reduced immunosuppressive properties.
M
orbilliviruses, including measles virus (MeV), which infects humans and certain nonhuman primates, and the carnivore morbillivirus canine distemper virus (CDV), cause a severe acute disease characterized by rash, fever, and respiratory and gastrointestinal symptoms, followed by generalized immunosuppression (1) (2) (3) . This rapid and profound immunosuppression facilitates secondary infections, which make important contributions to morbillivirus-associated morbidity and mortality (4, 5) . The morbillivirus V protein is the primary viral immune interference protein, targeting the innate host response at multiple levels (6) (7) (8) . The V-protein mRNA is transcribed from the phosphoprotein (P) gene by insertion of a nontemplated guanosine at an editing site located in the middle of the gene (9, 10) . Consequently, V shares its amino-terminal part with P, but has a unique carboxy terminus. The latter contains a cysteine-rich domain, which binds two atoms of zinc (11, 12) and is highly conserved among morbilliviruses and other paramyxoviruses (13) .
The shared amino-terminal domain and the unique carboxylterminal domain contribute to the innate immunity-interfering functions of morbillivirus V protein. The P/V shared domain alone can block type I and type II interferon (IFN) responses. This activity has been mapped to amino acids 110 to 130, with tyrosine 110 being essential for binding the signal transducer and activator of transcription 1 (STAT1) molecule (14) (15) (16) . Inactivation of the zinc-binding domains in the V-protein unique region results in a 70% loss of its type I IFN inhibitory activity (8) , and this region can directly inhibit beta interferon (IFN-␤) synthesis by interacting with the double-stranded RNA sensor melanoma differentiation-associated gene 5 (mda5) (7, 17, 18) . Systematic mutagenesis of the entire region revealed that aspartic acid at position 248 and, to a lesser extent, phenylalanine 246 are important for the inhibition of STAT2 nuclear translocation (6, 8) . Similarly, it was demonstrated that a conserved arginine at position 235 is required for mda5 interference in several paramyxoviruses (19) . The STAT2 and mda5 interaction sites of the MeV carboxyl-terminal domain are thus located at opposite sides of the first zinc-binding domain, which is formed between histidine at position 232 and the first conserved cysteine at position 251.
Relevance of morbillivirus V proteins for virulence has been demonstrated in different susceptible hosts. Rhesus macaques infected with a V-knockout (Vko) wild-type MeV experienced shorter viremia and less immunosuppression (20) , and infection with a STAT1blind virus resulted in a similar phenotype (21) . In ferrets, a Vko derivative of a lethal wild-type CDV strain caused only a very mild disease and no longer triggered the inhibition of lymphocyte proliferation upon nonspecific stimulation that is indicative of immunosuppression (22) . To assess the contributions of the different V-protein interactions to the control of innate immunity, we first validated the residues involved in V-protein interactions with STAT2 and mda5 in the CDV context. A panel of STAT1-, STAT2-, mda5-, and combined STAT2/mda5-blind derivatives of the 5804P wild-type CDV strain was generated, and their growth phenotypes were characterized in vitro. The virulence and extent of immunosuppression were then assessed in ferrets, and the extent of IFN induction was quantified. (23) and Huh7 cells (JCRB0403) were maintained in Dulbecco's modified Eagle's medium (Life Technologies, Burlington, ON, Canada) with 5% fetal bovine serum (Life Technologies). CDV strains 5804PeH (24) and 5804PeH Vko (22) , and all recombinant viruses produced were grown in VerodogSLAMtag cells.
MATERIALS AND METHODS

Cells and viruses. VerodogSLAMtag cells
Luciferase reporter gene assays. The 5804P V gene was cloned into the mammalian expression plasmid pCG, and the respective mutations and the individual mutations W246G, I247L, D248Y, and K249E were introduced by site-directed mutagenesis. For each V-protein mutant, triplicate wells of Huh7 cells seeded in black 96-well plates (Greiner BioOne, Monroe, NC, USA) were transfected using Lipofectamine 2000 (Invitrogen, Burlington, ON, Canada) with 0.08 g of the respective V-gene expression plasmid or empty vector control, 0.04 g of pRL-TK (Promega, Madison, WI, USA) as an internal control for transfection efficiency, and 0.08 g of either pISRE-Luc (Luc stands for luciferase) (Stratagene, La Jolla, CA, USA) to assess type I IFN-mediated transcriptional activation, pGAS-luc (Stratagene) for IFN-␥-mediated activation, or p125-luc together with mda5 or RIG-I (retinoic acid-inducible gene I product) expression plasmids for IFN-␤ promoter activation. At 40 h after pISRE-Luc transfection, the medium was replaced with fresh medium supplemented with 1,000 U/ml of universal type I IFN-␣ (PBL Interferon Source, Piscataway, NJ, USA). To assess pGAS-luc-mediated or IFN-␤ promoter activation, the medium was replaced 24 h after transfection with fresh medium supplemented with 100 ng/ml of human IFN-␥ (PBL Interferon Source) or 1 g/ml of poly(I·C) (LyoVec; InvivoGen, San Diego, CA, USA), respectively. Cells were harvested 8 h after IFN-␣ stimulation, 18 h after IFN-␥ stimulation, or 20 h after poly(I·C) stimulation in Dual-Glo luciferase assay lysis buffer (Promega), and luciferase activity was measured using a luminometer (Infinite 200 PRO microplate reader; Tecan Asia Ptd. Ltd., Singapore). Values for firefly luciferase activity were normalized to Renilla luciferase activity, and results were expressed as a percentage of the empty vector control stimulated value. Each luciferase assay was performed at least three times.
Antibodies and indirect immunofluorescence. CDV V protein was detected with a polyclonal rabbit antipeptide serum raised against amino acids 18 to 39 of the shared P/V domain (25) . STAT1 and STAT2 were detected using commercially available monoclonal antibodies (C-111 and A-7, respectively; Santa Cruz Biotechnology, Santa Cruz, CA, USA). Alexa Fluor 568-conjugated donkey anti-rabbit (Life Technologies) and Alexa Fluor 647-conjugated goat anti-mouse (Life Technologies) secondary antibodies were used. For immunofluorescence analysis, 4 ϫ 10 4 Huh7 cells were grown in Nunc Lab-Tek II 8-chamber slide system (Thermo Fisher, Langenselbold, Germany) and transfected with 0.2 g of empty vector or V-expressing plasmids using Lipofectamine 2000 according to the manufacturer's instructions. At 36 h posttransfection, cells were stimulated with 1,000 U/ml IFN-␣2b (Essex Pharma GmbH, Munich, Germany) or 2,000 U/ml of human IFN-␥ (Preprotech, Hamburg, Germany) for 30 min. The cells were then washed with phosphate-buffered saline (PBS) (Life Technologies), fixed with 4% paraformaldehyde in PBS for 10 min at room temperature, and permeabilized with 0.1% Triton X-100 in PBS for 5 min at 4°C. Samples were blocked with 2% fetal bovine serum for 1 h followed by sequential incubation with the respective primary and secondary antibodies for 45 min and 30 min at room temperature, respectively. Finally, cell nuclei were stained with 4=,6-diamidino-2-phenylindole (DAPI) for 1 min at room temperature. Images were obtained using a confocal microscope (Olympus FluoView 1000) during 405-nm, 561-nm, and 633-nm laser stimulation using an UOlanSApo 60ϫ/1.35 oil objective. Colocalization was analyzed using the ImageJ software Intensity correlation analysis plugin (National Institutes of Health). Pearson's coefficients were calculated for every cell individually by manually defining the region of interest. Values Ϫ1 to 0 indicate no colocalization, values around zero represent random distribution (no correlation), and values 0 to 1 indicate colocalization. The higher the Pearson's coefficient, the stronger the degree of colocalization.
Western blot analysis. VerodogSLAMtag cells were plated at a density of 5 ϫ 10 5 cells per well in a 6-well plate, infected with the respective viruses at a multiplicity of infection (MOI) of 0.1, and incubated at 37°C for 48 h. For the analysis of viral protein expression, cells were lysed in radioimmunoprecipitation assay (RIPA) buffer (1 mM phenylmethylsulfonyl fluoride, 1% sodium deoxycholate, 50 mM Tris-HCl [pH 7.4], 1% Triton X-100, 0.1% SDS, 150 mM NaCl), and proteins were separated by SDS-polyacrylamide gel electrophoresis followed by transfer to polyvinyl difluoride membranes (Merck Millipore, Billerica, MA, USA). P and V proteins were detected using the CDV P/V-specific rabbit antipeptide antiserum against the P/V shared domain (25) in combination with a peroxidase-coupled donkey anti-rabbit secondary antiserum and visualized using ECL Plus Western blotting detection system (GE Healthcare, Pittsburgh, PA, USA) and an ImageQuant LAS 4000 chemiluminescent image analyzer (GE Healthcare).
Generation of recombinant viruses. The mutations resulting in the amino acid substitution Y110H, E235A, WI246/7GL, and C255S (Fig. 1A) were introduced into a subcloned P gene fragment flanked by the unique restriction sites KpnI and SacII. The fragment was then transferred into the 5804PeH genomic cDNA containing the enhanced green fluorescent protein (eGFP) in an additional transcriptional unit between the hemagglutinin (H) and polymerase (L) genes. Recombinant viruses were recovered using the reverse genetics system described in reference 25. Briefly, 293 cells were transfected with expression plasmids encoding the MeV nucleoprotein (N), phosphoprotein (P), and polymerase (L) protein and the T7 polymerase, together with the respective genomic 5804PeH plasmid. Two days after transfection, the cells were transferred onto VerodogSLAMtag cells, and individual syncytia were picked and expanded on fresh VerodogSLAMtag cells to produce virus stocks. Virus titers were quantified by the limited dilution method and expressed as 50% tissue culture infectious doses (TCID 50 ).
Animal experiments and assessment of virulence. All animal experiments were approved by the INRS-Institut Armand-Frappier or SingHealth Institutional Animal Care and Use Committees. Groups of at least six CDV-seronegative male ferrets (Mustela putorius furo) were infected intranasally with 10 5 TCID 50 of each virus as described previously (22) .
Rash, fever, and weight loss were assessed daily and graded on a scale from 0 to 2 (scored as 0, 1, and 2). The total white blood cell count was determined from fresh EDTA-treated blood diluted 1:100 in 3% acetic acid, and the viremia and lymphocyte proliferation activity were quantified. Briefly, the erythrocytes in the EDTA-treated blood were lysed in ACK lysing buffer (Life Technologies). The white blood cells were then counted, and 10-fold dilution steps were transferred onto VerodogSLAMtag cells. Titers were expressed as TCID 50 /10 6 cells. At the last time point of virus detection in peripheral blood mononuclear cells (PBMCs), RNA was isolated from the remaining cells stored in RNAlater (Life Technologies), and the region of the P gene containing the mutation was amplified by reverse transcription-PCR (RT-PCR) and sequenced.
Ficoll (GE Healthcare) density gradient centrifugation was used to isolate PBMCs from heparinized blood. The proliferation of PBMCs after stimulation with 15 g/ml of phytohemagglutinin (PHA) (Life Technologies) was quantified using a chemiluminescence immunoassay based on the measurement of 5-bromo-2=-deoxyuridine (BrdU) incorporation during DNA synthesis (Roche Applied Science, Indianapolis, IN). The in vitro proliferation activity was expressed as the ratio between PHA-stimulated and nonstimulated cells.
IFN mRNA analysis. Relative IFN-␣, IFN-␤, and IFN-␥ mRNA levels were analyzed by semiquantitative real-time PCR analysis as described previously (26) . Briefly, mRNA was isolated from PBMCs of infected ferrets using the RNeasy minikit (Qiagen, Mississauga, ON, Canada). Ten ng of RNA together with specific primers against ferret IFN-␣, -␤, or -␥ was mixed with the QuantiTect SYBR green RT-PCR master mix (Qiagen) following the manufacturer's instructions. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA transcription was used as an internal control, and mRNA levels were normalized to day 0 values. The relative change in transcription levels was calculated using the formula fold change ϭ 2
Ϫ⌬⌬Ct to evaluate fold transcription (26, 27) .
RESULTS
The STAT1, STAT2, and mda5 interaction sites in the V protein are conserved between MeV and CDV. Morbilliviruses interfere with IFN activation by preventing the nuclear translocation of STAT1 and STAT2 (28) as well as downstream signaling through the intracellular pattern recognition receptor mda5 (7, 29) . The V-protein residues involved in these functions have been mapped for MeV (8, 19) , and the importance of Y110H for STAT1 binding and the region for STAT2 and mda5 interactions has been demonstrated for other morbilliviruses (16, 30) . To investigate the roles of the different signaling pathways in morbillivirus pathogenesis, we selectively generated STAT1-, STAT2-, or mda5-blind CDV V proteins and a V protein with a disrupted zinc-binding domain (ZBDko) in the genetic background of the wild-type strain 5804P. To specifically abolish STAT2 binding while maintaining the P open reading frame, the combination of the two point mutations W246G and I247L in the STAT2-binding region covering residues 240 to 250 identified in MeV V (8) was required ( Fig. 1A and 2A and B). The WI246/7GL protein was STAT2blind but continued to block STAT1 signaling and IFN-␤ promoter activation (Fig. 1B  to D ). To generate a STAT1blind derivative, the Y110H mutation was introduced into the P/V shared amino-terminal part of the V protein, and the E235A and C255S mutations were introduced into the V-protein unique region (Fig. 2B ) to obtain the mda5 and ZBDko derivatives, respectively ( Fig. 2A) .
The interference of the parental V protein and the four mutant V proteins with IFN signaling activation was evaluated using luciferase reporter gene assays. After transfection in Huh7 cells, all V proteins were expressed at similar levels (data not shown). Reporter plasmids carrying firefly luciferase under the control of either the IFN-␥-activated sequence (GAS) to evaluate STAT1-mediated type II IFN signaling activation, repetitive sequences of the IFN-stimulated response element (ISRE) to evaluate STAT1/ STAT2 heterodimer-dependent type I signaling, or the IFN-␤ promoter in combination with mda5 or RIG-I expression plasmids were used. While the wild-type V protein strongly inhibited 
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IFNβ-luc GAS-luc ISRE-luc the induction of all these pathways, the respective signaling activity was selectively restored for the STAT1blind, STAT2blind, and mda5blind V protein mutants ( Fig. 2C to E) . However, in contrast to the type II IFN-and mda5-dependent signaling pathways, which were fully inhibited by all other mutants ( Fig. 2C and E) , a partial but significant (P Ͻ 0.001) loss of type I IFN signaling inhibition was also observed for the STAT1blind V protein and even more for the mda5blind V protein. Disruption of the zincbinding domain in the V-protein carboxy terminus, which is highly conserved among all paramyxoviruses, prevented interference with the STAT2 and mda5 signaling pathways at levels close to the respective individual STAT2blind and mda5blind mutants ( Fig. 2D and E) . Consistent with previous reports (7), RIG-I overexpression prevented the CDV V-protein-mediated inhibition of IFN-␤ promoter activation (data not shown). STAT1blind and STAT2blind CDV V proteins selectively lose their ability to prevent nuclear translocation of the respective STAT protein. Morbillivirus V proteins prevent type I and II IFN signaling by retaining STAT1 and STAT2 in the cytoplasm (16, 28) . To evaluate the extent of STAT1 and STAT2 nuclear translocation inhibition associated with the different mutants, the intracellular distribution of the respective proteins was quantified by confocal microscopy after stimulation with IFN-␥ and IFN-␣, respectively. As reported previously (16), the wild-type CDV V protein efficiently blocked STAT1 and STAT2 nuclear translocation, while the STAT1blind mutant was no longer able to prevent STAT1 translocation (Fig. 3) . The STAT2blind mutant no longer affected STAT2 distribution, while the mda5blind and ZBDko mutants retained their ability to block STAT1 and STAT2 nuclear translocation, albeit to a lesser extent than the wild-type CDV V protein (Fig. 4) . The complete loss of type I IFN signaling inhibition seen for the ZBDko mutant (Fig. 2D ) may thus be due to an additive effect of partial STAT2 cytoplasmic retention and the lack of mda5-mediated signaling (Fig. 2D ) associated with this mutant.
Viruses carrying mutant V proteins replicate efficiently in IFN signaling-deficient cells. To evaluate V-protein interference with the different IFN signaling pathways in the viral context, we introduced the respective mutations into the genome of 5804PeH, which expresses eGFP from an additional open reading frame inserted between the H and L genes (24) . The Vko virus from a previous study was included as a control for complete loss of Vprotein function (22) . Western blot analysis revealed that all mutant V proteins were efficiently expressed and that the P-to-V ratios remained around 1:1 (Fig. 5A and data not shown) . Time course analysis of cell-associated and cell-free virus production revealed similar replication efficiencies during early infection stages ( Fig. 5B and C) . While the replication kinetics of the STAT1blind virus were similar to that of the parental wildtype virus throughout, the cell-associated virus titers of the STAT2blind virus and to a lesser extent the mda5blind virus were significantly lower at later time points (P Ͻ 0.05 to 0.01), even though the cytopathic effects were similar ( Fig. 5B and D) . These viruses and the Vko and ZBDko mutants also yielded significantly (P Ͻ 0.05 to 0.001) lower cell-free virus titers at the latest time point (Fig. 5C) , suggesting that the V-protein unique region may influence directly or indirectly virus replication. However, the peak titers reached and the overall replication kinetics were within the range observed for different wild-type viruses. CDV virulence requires inhibition of STAT2 and mda5 signaling. To assess the importance of the V-protein-mediated inhibition of the different IFN signaling pathways in vivo, groups of six to eight ferrets were infected intranasally with each mutant virus, the wild-type virus, and the Vko virus. All animals infected with the wild-type or STAT1blind viruses developed a severe rash, high fever, and substantial weight loss and ultimately succumbed to the disease within 2 weeks after infection (Fig. 6A) . In contrast, only a mild and transient disease was observed in the groups of ferrets infected with Vko or ZBDko virus. Ferrets infected with mda5blind and STAT2blind viruses presented an intermediate disease phenotype with clinical signs of various intensities. However, all animals ultimately survived the infection. Consistent with the clinical course, cell-associated viremia levels observed for the STAT1blind virus were similar to those observed for the wild-type strain (Fig. 6B) . In contrast, all other V-protein mutants reached a hundred-fold-lower peak titer, and the viremia was cleared within 3 weeks. None of the viruses reverted to the wild-type sequence or accumulated additional changes in the region surrounding the original mutation (data not shown). All viruses resulted in severe leukopenia within 7 days after infection, which resolved rapidly in animals infected with Vko, mda5/STAT2blind, or STAT2blind viruses, while progressively worsening in animals infected with lethal STAT1blind or wildtype strains (Fig. 6C) . Despite the survival of all animals infected with the mda5blind virus, leukocyte numbers remained reduced until the end of this study at 35 days postinfection. Similarly, an inhibition of lymphocyte proliferation was observed in all groups during the acute infection stages, with the exception of the Vkoinfected animals (Fig. 6D) . The values remained low in the animals infected with the lethal viruses and recovered only slowly in the mda5 and combined STAT2/mda5blind groups. In contrast, lack of interference with STAT2-mediated IFN signaling resulted in a rapid recovery of proliferation activity.
STAT1blind virus remains virulent despite reduced control of type I IFN responses in vivo. Lethal CDV infections in ferrets are characterized by complete inhibition of cytokine responses (26) . To assess whether the loss of type I and II IFN signaling interference observed in vitro alters the IFN induction profile in vivo, we analyzed the IFN mRNA levels in PBMCs 3 days after infection. Consistent with our previous findings, ferrets infected with the parental wild-type strain were unable to upregulate type I and II IFN mRNAs, while the group infected with Vko virus mounted a vigorous response (22) (Fig. 7A to C, WT and Vko columns). All viruses that carried V proteins with mutations that selectively abolished their ability to interfere with one of the IFN signaling pathways resulted in an intermediate phenotype (Fig. 7A to C) . IFN-␥ induction in these animals was less homogeneous, with some animals responding strongly and others showing inhibition similar to that of the group infected with wild-type virus (Fig. 7C) . While the STAT1blind mutant retained wild-type virulence despite its reduced ability to prevent IFN induction in PBMCs 3 days postinfection, the STAT2blind, mda5blind, and ZBDko viruses that also had reduced ability to prevent IFN induction were attenuated. This suggests that virus-host interactions in other cells, or downstream IFN signaling events, must influence disease outcome. 
DISCUSSION
Morbillivirus V-protein-mediated interference with innate immune activation has been the focus of intense study over the last years. It is now clear that V protein inhibits the nuclear translocation of STAT1 and STAT2, thereby interfering with type I and II IFN-mediated transcriptional activation (16, 28, 30) . In addition, V protein inhibits mda5 signaling (19) . Naturally occurring mutations and systematic screening have identified the region around residue Y110 as essential for STAT1 interactions (6, 14, 31) and have highlighted the importance of regions R233-E235 and W240-W250 in the V-protein unique region for mda5 signaling interference and STAT2 binding, respectively (6, 8) . Independent of these in vitro mechanistic analyses, the importance of the V protein for virulence has been demonstrated in different animal with the parental strain 5804PeH (WT), the Vko derivative, or the different mutant viruses. RNA was isolated from PBMCs on day 0 and 3 postinfection, and PCR assays were conducted using primers specific for the genes indicated at the top of each panel (IFN-␣, IFN-␤, and IFN-␥). The fold change ratios between experimental and control samples for each gene were calculated and normalized against GAPDH using the ⌬⌬C T method. Error bars represent the SEM. Asterisks show the levels of statistical significance as follows: ‫,ءء‬ P Ͻ 0.01; ‫,ءءء‬ P Ͻ 0.001. models (20, 22, 32) , and a STAT1blind virus displayed a Vko phenotype in rhesus macaques (21) . However, the relative importance of the V-protein interactions with the different IFN signaling pathways for virulence and innate immune response control remained to be determined. We present here such an analysis based on infection of ferrets with a lethal CDV strain. Surprisingly, we found that loss of the ability to interfere with STAT1 signaling had no effect on the severity of immunosuppression and the outcome of the infection in ferrets, even though this virus was unable to prevent activation of type I and II IFN transcription in PBMCs.
Control of STAT2 and mda5-mediated signaling is critical for morbillivirus virulence. RNA virus infections are first detected by the intracellular RNA sensors RIG-I and mda5, triggering the transcription of IFN-␤, which in turn initiates a signaling cascade that ultimately leads to phosphorylation of tyrosine residues in STAT molecules and their nuclear translocation (33) . The best-characterized IFN signaling pathway involves the binding of phosphorylated STAT1/2 molecules to interferon regulatory factor 9 (IRF9), which leads to the formation of interferon-stimulated gene factor 3 (ISGF3) and subsequent transcription of ISREcontrolled genes (34) . In addition, other mechanisms of signaling exist, and there is increasing evidence that STAT1, STAT3, STAT4, STAT5, and STAT6 homodimers, as well as STAT1/3, STAT1/4, STAT1/5, STAT2/3 and STAT5/6 heterodimers also engage in signal transduction (35, 36) . Furthermore, interferon-stimulated genes (ISGs) cannot be induced upon stimulation with IFN in an ISRE-dependent manner in the presence of p38 inhibitors (37) , indicating that STAT-independent signaling via p38 and mitogenactivated protein kinases (MAPK) contributes significantly to IFN-mediated transcription initiation (35) . Altogether, these in vitro and knockout mouse studies suggest that several different pathways of interferon signaling are operative, but it is not yet known which are more relevant for the control of virulence in natural hosts. We observed that functional inactivation of V-protein-meditated inhibition of STAT2-or mda5-mediated signaling results in attenuation, demonstrating that interference at several key points in the innate immune recognition pathway is necessary for the virus to achieve full control.
Minor role of STAT1 signaling in host response to CDV. The increased susceptibility of STAT1ko mice, and of patients with genetic defects in STAT1, to many viral diseases illustrates its importance in the activation of the host response to infections (38, 39) . Together with an earlier report that MeV inhibits the maturation of SLAM-expressing STAT2ko but not STAT1ko murine dendritic cells (40) , our observation that the inhibition of STAT1-mediated signaling has little effect on CDV virulence in ferrets indicates that the STAT1 signaling pathway plays only a minor role in the control of these infections in a natural host. However, a similarly constructed STAT1blind measles virus was attenuated in rhesus macaques (21) . The relative importance of the interactions of the V proteins of morbilliviruses with the immune defenses of different hosts may thus vary.
V-protein interference with additional signaling or effector proteins and disease severity. We observed that all viruses with IFN signaling interference-deficient V proteins partially lost their competence to control IFN activation in ferret PBMCs, but only the STAT1blind CDV retained wild-type virus-like virulence. It is conceivable that early CDV interactions with macrophages and dendritic cells of the respiratory tract determine disease outcome, as these cells were found to be infected during early MeV infection stages (41) . These professional antigen-presenting cells rapidly express high levels of type I IFNs upon exposure of Toll-like receptors to single-stranded RNA (42) . The MeV V protein inhibits this pathway by competing with IRF7 for phosphorylation (43) , and high structural and functional conservation suggests that the CDV V protein has similar activity.
Differences in the interference of the mutants with downstream IFN signaling may also contribute to disease outcome. While small amounts of type I or II IFN can be sufficient to trigger the expression of ISGs (33) , there are several positive-and negative-feedback loops to adapt the level of expression to the respective situation (44, 45) . It is conceivable that V protein interacts with certain groups of ISGs in a yet unknown manner and that these interactions may modulate virulence. Identification and characterization of these candidate additional V-protein targets may thus be needed to fully understand the multifaceted interaction between morbilliviruses and the host's immune system.
